- Home
- MGRM vs DERM Comparison
MGRM vs DERM Comparison
Compare MGRM & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- DERM
- Stock Information
- Founded
- MGRM 2016
- DERM 2014
- Country
- MGRM United States
- DERM United States
- Employees
- MGRM N/A
- DERM N/A
- Industry
- MGRM Medical/Dental Instruments
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- MGRM Health Care
- DERM Health Care
- Exchange
- MGRM Nasdaq
- DERM Nasdaq
- Market Cap
- MGRM 195.3M
- DERM 165.6M
- IPO Year
- MGRM N/A
- DERM 2021
- Fundamental
- Price
- MGRM $5.35
- DERM $7.25
- Analyst Decision
- MGRM Strong Buy
- DERM Strong Buy
- Analyst Count
- MGRM 1
- DERM 2
- Target Price
- MGRM $5.40
- DERM $12.50
- AVG Volume (30 Days)
- MGRM 225.3K
- DERM 164.6K
- Earning Date
- MGRM 08-18-2025
- DERM 08-12-2025
- Dividend Yield
- MGRM N/A
- DERM N/A
- EPS Growth
- MGRM N/A
- DERM N/A
- EPS
- MGRM N/A
- DERM N/A
- Revenue
- MGRM N/A
- DERM $56,397,000.00
- Revenue This Year
- MGRM N/A
- DERM $28.99
- Revenue Next Year
- MGRM N/A
- DERM $52.61
- P/E Ratio
- MGRM N/A
- DERM N/A
- Revenue Growth
- MGRM N/A
- DERM N/A
- 52 Week Low
- MGRM $1.92
- DERM $3.54
- 52 Week High
- MGRM $6.02
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- MGRM 63.65
- DERM 47.98
- Support Level
- MGRM $5.29
- DERM $6.90
- Resistance Level
- MGRM $5.53
- DERM $8.90
- Average True Range (ATR)
- MGRM 0.12
- DERM 0.45
- MACD
- MGRM -0.13
- DERM 0.03
- Stochastic Oscillator
- MGRM 23.08
- DERM 26.01
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.